Author

Jinchan Qu

Observed name: Qu, Jinchan

Institution: Sumitomo Dainippon Pharma (United States)

Observed institutions: Florida State University, Sumitomo Dainippon Pharma (United States)

OpenAlex ID: A5019382525

Overview of the BioCreative VI Precision Medicine Track: mining protein interactions and mutations for precision medicine

2018 · Rezarta Islamaj Doğan, Sun Kim, et al. · Database · 76

Triage of documents containing protein interactions affected by mutations using an NLP based machine learning approach

2020 · Jinchan Qu, Albert Steppi, et al. · BMC Genomics · 9

Simulation Study on a New Peer Review Approach

2018 · Steppi, Albert, Qu, Jinchan, et al. · arXiv (Cornell University) · 1

First data disclosure from the first-in-human phase 1/2 trial of SMP-3124LP, the first investigational pegylated liposome CHK1 inhibitor, in patients with selected advanced solid tumors.

2026 · Timothy A. Yap, Kenichi Harano, et al. · Journal of Clinical Oncology

Applications of Machine Learning to Precision Medicine

2019 · Jinchan Qu

Works count: 5

Citation count: 86

H-index: 2

I10-index: 1